Wayne Kuznar

San Francisco - A baseline examination followed by yearly screening for retinopathy is probably adequate for patients taking chronic antimalarial therapy, Stephen E. Wolverton, M.D., said.

San Francisco - Individualization of drug therapy is becoming a reality with the recognition that the response to drugs varies as a result of sequence variants in genes encoding drug-metabolizing enzymes, drug transporters, or drug targets.

San Francisco - Compared with first-generation antihistamines, second-generation agents are more specific antihistamine antagonists that are less sedating and have a longer half-life, Michael D. Tharp, M.D., said.